Legacy Advisors, LLC Vertex Pharmaceuticals Inc Transaction History
Legacy Advisors, LLC
- $978 Million
- Q4 2024
A detailed history of Legacy Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Legacy Advisors, LLC holds 889 shares of VRTX stock, worth $447,344. This represents 0.04% of its overall portfolio holdings.
Number of Shares
889
Previous 790
12.53%
Holding current value
$447,344
Previous $367,000
2.45%
% of portfolio
0.04%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding VRTX
# of Institutions
1,764Shares Held
228MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$14.3 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.7 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.7 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$6.03 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.25 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $129B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...